Serum FGF21 levels are associated with brown adipose tissue activity in humans

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hanssen, Mark J W ^a   Broeders, Evie ^a   Samms, Ricardo J ^b   Vosselman, Maarten J ^a   Van Der Lans, Anouk A J J ^a   Cheng, Christine C ^b   Adams, Andrew C ^b   Van Marken Lichtenbelt, Wouter D ^a   Schrauwen, Patrick ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21;

ADULT; BLOOD; BROWN ADIPOSE TISSUE; ENERGY METABOLISM; FEMALE; HUMAN; MALE; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; THERMOGENESIS; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADIPOSE TISSUE, BROWN; ADULT; ENERGY METABOLISM; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; THERMOGENESIS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84929415426     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10275     Document Type: Article

References (38)

1. Nishimura, T., Nakatake, Y., Konishi, M. & Itoh, N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 1492, 203-206 (2000).
2. Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635 (2005).
3. Adams, A. C. et al. LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys. PloS one 8, e65763 (2013).
4. Adams, A. C. et al. Fundamentals of FGF19 & FGF21 action in vitro and in vivo. PLoS One 7, e38438 (2012).
5. Wente, W. et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55, 2470-2478 (2006).
6. Coskun, T. et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018-6027 (2008).
7. Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250-259 (2009).
8. Fisher, F. M. et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26, 271-281 (2012).
9. Chau, M. D., Gao, J., Yang, Q., Wu, Z. & Gromada, J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc. Natl. Acad. Sci. USA. 107, 12553-12558 (2010).
10. Gaich, G. et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 18, 333-340 (2013).
11. van Marken Lichtenbelt, W. D. et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508 (2009).
12. Virtanen, K. A. et al. Functional brown adipose tissue in healthy adults. The N. Engl. J. Med. 360, 1518-1525 (2009).
13. van der Lans, A. A. et al. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J. Clin. Invest. 123, 3395-3403 (2013).
14. Tseng, Y. H. et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454, 1000-1004 (2008).
15. Whittle, A. J. et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149, 871-885 (2012).
16. Bostrom, P. et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468 (2012).
17. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
18. Lee, P. et al. Mild cold exposure modulates fibroblast growth factor 21 (FGF21) diurnal rhythm in humans: relationship between FGF21 levels, lipolysis, and cold-induced thermogenesis. J. Clin. Endocrinol. Metab. 98, E98-102 (2013).
19. Hondares, E. et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J. Biol. Chem. 286, 12983-12990 (2011).
20. Chartoumpekis, D. V. et al. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol. Med. 17, 736-740 (2011).
21. Badman, M. K. et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426-437 (2007).
22. Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-425 (2007).
23. Lee, P. et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 19, 302-309 (2014).
24. Vosselman, M. J. et al. Systemic beta-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans. Diabetes 61, 3106-3113 (2012).
25. Vosselman, M. J. et al. Brown adipose tissue activity after a high-calorie meal in humans. Am. J. Clin. Nutr. 98, 57-64 (2013).
26. Hanssen, M. J. et al. Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance. Diabetologia 58, 586-595 (2015).
27. van der Lans, A. A. et al. Cold-activated brown adipose tissue in human adults: methodological issues. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R130-R113 (2014).
28. Patlak, C. S., Blasberg, R. G. & Fenstermacher, J. D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3, 1-7 (1983).
29. Orava, J. et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 14, 272-279 (2011).
30. Andersen, B., Beck-Nielsen, H. & Hojlund, K. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers. Clin. Endocrinol. 75, 514-519 (2011).
31. Oishi, K., Uchida, D. & Ishida, N. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. FEBS letters 582, 3639-3642 (2008).
32. Antonellis, P. J., Kharitonenkov, A. & Adams, A. C. FGF21: insights into mechanism of action from preclinical studies. J. Anim. Sci. 92, 407-413 (2014).
33. Kharitonenkov, A. & Adams, A. C. Inventing new medicines: The FGF21 story. Mol. Metab. 3, 221-229 (2014).
34. Camporez, J. P. et al. Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice. Endocrinology 154, 3099-3109 (2013).
35. Yu, H. et al. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. Clin. Chem. 57, 691-700 (2011).
36. Veniant, M. M. et al. FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice. PLoS One 7, e40164 (2012).
37. Cuevas-Ramos, D. et al. Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS One 7, e38022 (2012).
38. Izumiya, Y. et al. FGF21 is an Akt-regulated myokine. FEBS letters 582, 3805-3810 (2008).